OrganTech Inc.
PrivateLast Round
Series D
Jun 3, 2026
Est. Valuation
$20.79M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
OrganTech Inc. operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Series D round in June 2026.
OrganTech Inc. is a biotechnology company that specializes in regenerative medicine, focusing on the development of bio-hybrid implants, hair follicle regeneration, and three-dimensional artificial skin technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OrganTech Inc. Comparables
Compare OrganTech Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 0913693 B.C. Ltd. | 77% | |
| Epibiotech Co., Ltd. | 66% | |
| Toregem BioPharma | 64% |
For institutional investors. Book with your work email.
OrganTech Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jun 3, 2026 | ||||
| Seed | Feb 10, 2023 | ||||
| VC Round | Jun 20, 2018 |
For institutional investors. Book with your work email.
OrganTech Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Iyogin Capital Company Limited | VC Round |
| Power Angels | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2026
Raised $20.79M in Series D funding.
- Jun 20, 2018
$5.36M raised from Itochu, Iyogin Capital, and Mitsui & Co.
For institutional investors. Book with your work email.
OrganTech Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OrganTech Inc.'s valuation, stock price, and market status.
Is OrganTech Inc. a public or private company?
OrganTech Inc. is a private company.
What is the current stock price of OrganTech Inc.?
OrganTech Inc. is a private company, so its shares have no public market price. Caplight tracks OrganTech Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OrganTech Inc. worth (valuation)?
OrganTech Inc.'s valuation is estimated at $20.8M based on funding round data.
Can I buy OrganTech Inc. stock?
OrganTech Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OrganTech Inc.'s last funding round?
OrganTech Inc.'s most recent funding round was Series D on June 3, 2026.
Who are the main investors in OrganTech Inc.?
Key investors in OrganTech Inc. include Iyogin Capital Company Limited, Power Angels.
Will OrganTech Inc. IPO soon?
No public IPO plans have been announced for OrganTech Inc..
How can I track OrganTech Inc. secondary market activity?
Caplight tracks bids, offers, and trades in OrganTech Inc.'s shares on secondary markets.